Quadrant Capital Group’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-681
Closed -$28.3K 2796
2023
Q2
$28.3K Buy
681
+368
+118% +$15.1K ﹤0.01% 1542
2023
Q1
$12.9K Sell
313
-321
-51% -$13.7K ﹤0.01% 1908
2022
Q4
$26.1K Buy
634
+360
+131% +$14.6K ﹤0.01% 1522
2022
Q3
$12K Buy
274
+25
+10% +$1.21K ﹤0.01% 1821
2022
Q2
$12K Buy
249
+46
+23% +$2.47K ﹤0.01% 1584
2022
Q1
$12K Buy
203
+187
+1,169% +$9.93K ﹤0.01% 1579
2021
Q4
$1K Buy
16
+3
+23% +$163 ﹤0.01% 2453
2021
Q3
$1K Buy
13
+9
+225% +$555 ﹤0.01% 2437
2021
Q2
$0 Hold
4
﹤0.01% 2620
2021
Q1
$0 Buy
+4
New +$240 ﹤0.01% 2487
2020
Q4
Sell
-19
Closed -$1K 2406
2020
Q3
$1K Hold
19
﹤0.01% 2109
2020
Q2
$1K Buy
+19
New +$1.1K ﹤0.01% 2173
2020
Q1
Sell
-428
Closed -$33K 2308
2019
Q4
$33K Hold
428
﹤0.01% 1530
2019
Q3
$27K Hold
428
﹤0.01% 1490
2019
Q2
$25K Hold
428
﹤0.01% 1554
2019
Q1
$24K Buy
+428
New +$22.7K ﹤0.01% 1495
2018
Q4
Sell
-10
Closed 2328
2018
Q3
$0 Hold
10
﹤0.01% 2207
2018
Q2
$0 Hold
10
﹤0.01% 2229
2018
Q1
$0 Sell
10
-391
-98% -$19.8K ﹤0.01% 2237
2017
Q4
$22K Sell
401
-29
-7% -$1.65K 0.01% 892
2017
Q3
$22K Buy
430
+397
+1,203% +$26.3K 0.01% 874
2017
Q2
$0 Hold
33
﹤0.01% 2112
2017
Q1
$1K Hold
33
﹤0.01% 1932
2016
Q4
$1K Sell
33
-27
-45% -$1.74K ﹤0.01% 1858
2016
Q3
$3K Hold
60
﹤0.01% 1406
2016
Q2
$3K Buy
60
+23
+62% +$1.24K ﹤0.01% 1380
2016
Q1
$1K Buy
+37
New +$1.68K ﹤0.01% 1648

Other funds holding NUVA

Quadrant Capital Group's NUVA Position: Q3 2023 in Review

Quadrant Capital Group sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 681 shares — an estimated $28.3K sold.

Quadrant Capital Group first reported a position in NUVA in Q1 2016 and held it in 27 quarters. The position peaked at $33K in Q4 2019. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Quadrant Capital Group reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Quadrant Capital Group sold 681 NuVasive, Inc. shares in Q3 2023, an estimated $28.3K.
  • Quadrant Capital Group first reported a position in NuVasive, Inc. in Q1 2016 and held it in 27 quarters.
  • Quadrant Capital Group's NuVasive, Inc. position peaked at $33K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Quadrant Capital Group's 13F filing for Q3 2023, filed 14 Nov 2023.